Imunon, Inc. (IMNN) analyst actions
Rating and price-target actions on IMNN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the IMNN overview →
2 measured IMNN analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| IMUNON Announces First Site Initiated for Pivotal Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer | Press release | -0.66% | +0.48% | |
| IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study | Press release | +4.01% | +0.00% |
Keep exploring
More IMNN: earnings → · SEC filings → · IMNN overview →